TP53 and ovarian carcinoma: Kaempferol upregulates the expression of Bcl-xL and downregulates that of p53 and Bax by inhibiting extracellular regulated protein kinases (ERK), NF-κB, and MyD88 expression in human ovarian cancer cells [59].